Study of STA-1 as an Add-on Treatment to Donepezil

Clinical trial NCT01255046 · UNKNOWN

Trial details

NCT number: NCT01255046
Sponsor: Sinphar Pharmaceutical Co., Ltd
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Alzheimer Disease

Start date: 2015-12-01
Primary completion: 2018-12-01
Enrollment: 136

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.